interesting study but several glaring issues...case control observational, so limited, weak confounded design, residual confounding risk, no matching, no control for co-morbidites, none for early treatment, none for natural immunity, use of PCR that was false positive, hospital treatment effects...so many issues many explain the estimates of effect. but interesting indeed. the patient important outcomes was one strength